Appointment signifies a pivotal move for Astraveus as it expands its executive team to advance its groundbreaking cell and gene therapy (CGT) manufacturing solutions PARIS, Dec. 12, 2023 /PRNewswire/ — Astraveus SAS (“Astraveus” or the “Company”), the creator of the end-to-end benchtop…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.